Matthew Cali, Deepali K Ernest, Luyu Xie, Jeffrey N Schellinger, M Sunil Mathew, Aparajita Chandrasekhar, Jane Guo, Gloria L Vega, Sarah E Messiah, Jaime P Almandoz
{"title":"Binge eating behaviours are associated with recurrent weight gain after metabolic and bariatric surgery.","authors":"Matthew Cali, Deepali K Ernest, Luyu Xie, Jeffrey N Schellinger, M Sunil Mathew, Aparajita Chandrasekhar, Jane Guo, Gloria L Vega, Sarah E Messiah, Jaime P Almandoz","doi":"10.1111/cob.12735","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recurrent weight gain (RWG) is a major post-operative challenge among metabolic and bariatric surgery (MBS) patients. Binge eating behaviours (BEB) and food addiction (FA) have been identified as significant predictors of post-MBS RWG. However, limited research has investigated their independent associations with post-MBS RWG.</p><p><strong>Methods: </strong>This cross-sectional study collected data via a self-reported questionnaire of post-MBS patient demographics and eating behaviours from a single-site academic obesity medicine program. The Binge Eating Scale and Yale Food Addiction Scale 2.0 collected data on BEB and FA exposure variables, respectively. ANOVA/chi-square tests determined bivariate associations with BEB and FA, while multivariable logistic regression models examined independent adjusted associations of BEB and FA with RWG% cut-offs.</p><p><strong>Results: </strong>Of the 294 MBS patients (90.48% female, and 51.71% non-Hispanic white), 42.3% had BEB, 12.55% had severe FA, 7.36% moderate FA, and 7.36% mild FA. After adjustment, BEB was significantly associated with all magnitudes of post-MBS RWG, with the highest odds observed at 50% RWG [OR = 3.07; 95% CI: 1.45, 6.49; p = 0.003]. FA was not significantly associated with post-MBS RWG.</p><p><strong>Conclusion: </strong>Results showed that BEB, but not FA, was associated with post-MBS RWG. MBS patient support teams should consider screening for BEB at post-MBS visits.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":" ","pages":"e12735"},"PeriodicalIF":2.2000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Obesity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/cob.12735","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Recurrent weight gain (RWG) is a major post-operative challenge among metabolic and bariatric surgery (MBS) patients. Binge eating behaviours (BEB) and food addiction (FA) have been identified as significant predictors of post-MBS RWG. However, limited research has investigated their independent associations with post-MBS RWG.
Methods: This cross-sectional study collected data via a self-reported questionnaire of post-MBS patient demographics and eating behaviours from a single-site academic obesity medicine program. The Binge Eating Scale and Yale Food Addiction Scale 2.0 collected data on BEB and FA exposure variables, respectively. ANOVA/chi-square tests determined bivariate associations with BEB and FA, while multivariable logistic regression models examined independent adjusted associations of BEB and FA with RWG% cut-offs.
Results: Of the 294 MBS patients (90.48% female, and 51.71% non-Hispanic white), 42.3% had BEB, 12.55% had severe FA, 7.36% moderate FA, and 7.36% mild FA. After adjustment, BEB was significantly associated with all magnitudes of post-MBS RWG, with the highest odds observed at 50% RWG [OR = 3.07; 95% CI: 1.45, 6.49; p = 0.003]. FA was not significantly associated with post-MBS RWG.
Conclusion: Results showed that BEB, but not FA, was associated with post-MBS RWG. MBS patient support teams should consider screening for BEB at post-MBS visits.
期刊介绍:
Clinical Obesity is an international peer-reviewed journal publishing high quality translational and clinical research papers and reviews focussing on obesity and its co-morbidities. Key areas of interest are: • Patient assessment, classification, diagnosis and prognosis • Drug treatments, clinical trials and supporting research • Bariatric surgery and follow-up issues • Surgical approaches to remove body fat • Pharmacological, dietary and behavioural approaches for weight loss • Clinical physiology • Clinically relevant epidemiology • Psychological aspects of obesity • Co-morbidities • Nursing and care of patients with obesity.